Journals in Immunopathogenesis

American Journal of Preventive Medicine

ISSN: 0749-3797
5 Year impact factor: 4.9
Impact factor: 4.3

A Journal of the American College of Preventive Medicine and the Association for Prevention Teaching and ResearchThe American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.For information on the American College of Preventive Medicine (ACPM) and the Association for Prevention Teaching and Research (APTR), visit their web sites at the following URLs: http://www.acpm.org/ and http://www.aptrweb.org

Antiviral Research

ISSN: 0166-3542
5 Year impact factor: 5
Impact factor: 4.5

Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identification and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses;assessments of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.

Autoimmunity Reviews

ISSN: 1568-9972
5 Year impact factor: 9.3
Impact factor: 9.2

Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439
5 Year impact factor: 5.5
Impact factor: 4.2

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiovascular diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunological diseasesInflammatory diseasesMetabolic diseasesMitochondrial diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computational (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descriptive or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparative Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.

Clinica Chimica Acta

ISSN: 0009-8981
5 Year impact factor: 3.7
Impact factor: 3.2

International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

Clinical Immunology

ISSN: 1521-6616
5 Year impact factor: 4.7
Impact factor: 4.5

Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor.Research Areas Include:• Ageing • Allergy • Autoimmunity • Biotechnology • Clinical Laboratory Immunology • HIV • Immunodermatology • Immunohematology • Immunotoxicology/Environmental • Infection and Immunity • Mucosal Immunity • Neuroimmunology • Primary Immunodeficiency • Transplantation • Tumor Immunology • VaccinesBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Clinical Immunology Communications

ISSN: 2772-6134

Clinical Immunology Communications is a new online only, open-access journal that publishes high-quality, peer-reviewed contributions in the evolving areas of clinical immunology.The journal considers submissions transferred from Clinical Immunology, as well as direct submissions on basic, translational and clinical studies in vitro and in vivo in animal models and in humans, to advance the understanding of cellular, biochemical and molecular aspects of clinical immunology for broad audiences.The ultimate goal of Clinical Immunology Communications is to provide readers with new information on a wide range of clinical immunology subjects including: (1) autoimmune diseases; (2) hypersensitivity and allergy; (3) tumor immunology; (4) immunodeficiencies; (5) immunity to infection including HIV; (6) vaccines; (7) transplantation; (8) new immunological methods and techniques. The types of manuscripts considered for publication will include: (1) original articles; (2) brief communications; (3) reviews; (4) case reports or case cohorts; (5) editorials (by invitation only); (6) guidelines (written by academic authorities and focusing on clinical diagnosis and/or treatment, or use of methodologies in clinical immunology).

Clinical Microbiology Newsletter

ISSN: 0196-4399

Clinical Microbiology Newsletter is published bi-monthly to to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinical Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-reviews Case presentationsMicrobe SnapshotsThese articles cover topics including:Minireviews on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispensable updates on important clinical problems that impact the clinical laboratory,Editorials and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens,Helpful tips on improving the laboratory workplace.

Clinics in Dermatology

ISSN: 0738-081X
5 Year impact factor: 3.1
Impact factor: 2.3

The official journal of the International Academy of Cosmetic Dermatology (IACD)Clinics in Dermatology brings you the most practical and comprehensive information on the treatment and care of skin disorders. Each issue features a Guest Editor and is devoted to a single timely topic relating to clinical dermatology.Clinics in Dermatology provides information that is...• Clinically oriented -- from evaluation to treatment, Clinics in Dermatology covers what is most relevant to you in your practice.• Authoritative -- world-renowned experts in the field assure the high-quality and currency of each issue by reporting on their areas of expertise.• Well-illustrated -- each issue is complete with photos, drawings and diagrams to illustrate points and demonstrate techniques.Now affiliated with the International Academy of Cosmetic Dermatology (IACD). Visit the IACD web site for more information.

Comparative Immunology Reports

ISSN: 2667-0119

Comparative Immunology Reports is a new, online only, open access journal and a companion title to the highly-regarded journals Fish & Shellfish Immunology and Developmental & Comparative Immunology.Comparative Immunology Reports publishes high-quality, peer-refereed contributions in all areas of immunology, including comparative aspects of immunity and the evolution of the immune system of vertebrates and invertebrates in a rapid open-access format. It accepts studies on the basic mechanisms of both the specific and non-specific defense systems, including cells, tissues, proteins and genes. Reports on the influence of environmental and intrinsic factors, response to pathogens and the mechanistic and functional aspects of immunity are welcomed.

Related subjects

Autoimmunity

Clinical immunology

Histocompatibility

Infection and immunity

Inflammation and allergy

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health